Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Nurix Therapeutics (NRIX) Interest & Investment Income: 2019-2024

Historic Interest & Investment Income for Nurix Therapeutics (NRIX) over the last 6 years, with Nov 2024 value amounting to $19.7 million.

  • Nurix Therapeutics' Interest & Investment Income fell 13.47% to $5.0 million in Q3 2025 from the same period last year, while for Aug 2025 it was $23.2 million, marking a year-over-year increase of 36.62%. This contributed to the annual value of $19.7 million for FY2024, which is 77.49% up from last year.
  • Per Nurix Therapeutics' latest filing, its Interest & Investment Income stood at $19.7 million for FY2024, which was up 77.49% from $11.1 million recorded in FY2023.
  • In the past 5 years, Nurix Therapeutics' Interest & Investment Income registered a high of $19.7 million during FY2024, and its lowest value of $823,000 during FY2021.
  • Over the past 3 years, Nurix Therapeutics' median Interest & Investment Income value was $11.1 million (recorded in 2023), while the average stood at $11.4 million.
  • In the last 5 years, Nurix Therapeutics' Interest & Investment Income slumped by 31.76% in 2021 and then spiked by 326.12% in 2022.
  • Over the past 5 years, Nurix Therapeutics' Interest & Investment Income (Yearly) stood at $1.2 million in 2020, then slumped by 31.76% to $823,000 in 2021, then spiked by 326.12% to $3.5 million in 2022, then spiked by 216.94% to $11.1 million in 2023, then spiked by 77.49% to $19.7 million in 2024.